Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Skin Neoplasms × Sirolimus × Clear all

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Myelodysplastic Syndromes 4 Graft vs Host Disease 4 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Lymphangioleiomyomatosis 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Burkitt Lymphoma 2 Brain Neoplasms 2 Anemia, Aplastic 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Soft Tissue Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1

Interventions

pembrolizumab 8 cemiplimab 5 Nivolumab 5 avelumab 3 encorafenib 2 binimetinib 2 Radiotherapy 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 lenvatinib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 Vemurafenib 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 Oxaliplatin 1 Observation 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Magnetic Resonance Spectroscopy 1 Infliximab 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05860881 2025-09-09

SiroSkin

Melanoma and Skin Cancer Trials Limited

Phase 3 Active not recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡